Global Multi Use Bioreactor Market, By Product Type (Benchtop Bioreactors (Up To 15L), Pilot Scale Bioreactors (15-1000L), Industrial Scale Bioreactors (>1000L)), Cell (Mammalian Cells, Bacterial Cells, Yeast Cells), Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy), Modality (Manual, Automatic, Semi-Automatic), Technology (Downstream, Upstream) – Industry Trends and Forecast to 2029.
Multi Use Bioreactor Market Analysis and Size
The broad application scope in the commercial production of biologicals drives bioreactors product adoption in the healthcare industry. Additionally, the expansion of research and development initiatives to support efficient, innovative medicines for cancer treatment is anticipated to drive the market demand for multi use bioreactors.
Data Bridge Market Research analyses that the multi use bioreactor market which was USD 7 billion in 2021, would rocket up to USD 24.58 billion by 2029, and is expected to undergo a CAGR of 17.00% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Multi Use Bioreactor Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Benchtop Bioreactors (Up To 15L), Pilot Scale Bioreactors (15-1000L), Industrial Scale Bioreactors (>1000L)), Cell (Mammalian Cells, Bacterial Cells, Yeast Cells), Molecule (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Stem Cells, Gene Therapy), Modality (Manual, Automatic, Semi-Automatic), Technology (Downstream, Upstream)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Sartorius AG (Germany), Thermo Fisher Scientific Inc. (U.S.), General Electric (U.S.), Eppendorf AG (Germany), Merck KGaA (Germany), Pall Corporation (U.S.), ZETA (India), PIERRE GUERIN (France), PRaj Hipurity Systems Limited (India), Bioengineering AG (Switzerland), Infors AG (Switzerland), Solaris Biotechnology Srl. (Italy), Bbi Biotech (Germany), PBS Biotech Inc. (U.S.), CerCell A/S (Denmark), GEA Group Aktiengesellschaft (Germany)
|
|
Market Opportunities
|
|
Market Definition
A bioreactor is a type of vessel used to conduct chemical reactions involving living things or compounds produced from them that are biochemically active. These bioreactors are typically cylindrical, have capacities ranging from litres to cubic metres, and are frequently constructed of stainless steel. It may also be used to describe a tool or method used in cell culture to develop tissues or cells. These tools are being developed for use in tissue engineering and biochemical/bioprocess engineering.
Multi Use Bioreactor Market Dynamics
Drivers
- Rise in chronic diseases
Chronic diseases are becoming more prevalent, improved technology is being used, biopharmaceutical businesses are using bioreactors, and more research and development projects. These factors are all anticipated to contribute to the multi use bioreactor market's rapid expansion. On the other hand, over the forecast period, there will be tremendous prospects for the growth of the multi use bioreactor market due to the increased need for personalized medications and the development of orphan drugs.
- Research and development activities
The need for clinical-stage bioreactors has also been fuelled by expanding R&D efforts for the worldwide development of preventative vaccines. For the production of the COVID-19 vaccine, Serum Institute of India Pvt. Ltd. (SIIPL) used CSR bioreactors that ABEC donated. As a result, the market will continue to expand significantly over the forecast period to increase bioreactors' deployment in several production facilities.
Opportunities
- Technological advancements in bioreactors
The market will rise in the coming years due to ongoing bioreactor features and processing improvements. Additionally, many firms are actively engaged in developing cutting-edge technology, such as integrated bioreactors, which are cost-effective enough to enable large-scale manufacturing and boost product demand. The simplicity of scaling up volume and big volume processing, increased efficiency, and simplification of in-vivo systems are only a few of the many advantages that advanced bioreactors provide.
Restraints/Challenges
On the other hand, the increasing concern regarding extractable along with limited capacity will obstruct the market's growth rate. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the multi use bioreactor market.
This multi use bioreactor market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the multi use bioreactor market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Multi Use Bioreactor Market
The sudden increase in COVID-19 viral cases has had a favorable effect on reactor demand. The demand for effective medications for treating diseases and vaccinations for preventing them likewise grows as these needs do. Numerous pharmaceutical and biopharmaceutical companies have increased the capacity of their manufacturing units in order to serve a large patient pool, which has fuelled the need for bioreactors during the epidemic.
Recent Development
- In April 2022, Merck announced that it would purchase Lonza's MAST platform, an automated aseptic bioreactor sampling system. These platforms assist users in optimising data while performing bioprocessing. The company will be able to grow its business in the market thanks to this acquisition
- In March 2020, General Electric Life Sciences sold the CYTIVA biopharma division to Danaher Corporation. This tactic has aided the business in expanding its product line for biopharma clients and improving market penetration
Global Multi Use Bioreactor Market Scope
The multi use bioreactor market is segmented on the basis of product type, cell, molecule, modality and technology. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Benchtop Bioreactors (Up To 15L)
- Pilot Scale Bioreactors (15-1000L)
- Industrial Scale Bioreactors (>1000L)
Cell
- Mammalian Cells
- Bacterial Cells
- Yeast Cells
Molecule
- Monoclonal Antibodies
- Vaccines
- Recombinant Proteins
- Stem Cells
- Gene Therapy
Modality
- Manual
- Automatic
- Semi-Automatic
Technology
- Downstream
- Upstream
Multi Use Bioreactor Market Regional Analysis/Insights
The multi use bioreactor market is analysed and market size insights and trends are provided by country, product type, cell, molecule, modality and technology as referenced above.
The countries covered in the multi use bioreactor market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the multi use bioreactor market due to the growing number of biopharmaceutical companies.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising occurrences of chronic diseases along with increasing research and developmental activities.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Multi Use Bioreactor Market Share Analysis
The multi use bioreactor market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to multi use bioreactor market.
Some of the major players operating in the multi use bioreactor market are:
- Sartorius AG (Germany)
- Thermo Fisher Scientific Inc. (U.S.)
- General Electric (U.S.)
- Eppendorf AG (Germany)
- Merck KGaA (Germany)
- Pall Corporation (U.S.)
- ZETA (India)
- PIERRE GUERIN (France)
- PRaj Hipurity Systems Limited (India)
- Bioengineering AG (Switzerland)
- Infors AG (Switzerland)
- Solaris Biotechnology Srl. (Italy)
- Bbi Biotech (Germany)
- PBS Biotech Inc. (U.S.)
- CerCell A/S (Denmark)
- GEA Group Aktiengesellschaft (Germany)
SKU-